Opus Genetics, Inc. (Nasdaq: IRD), a clinical-stage ophthalmic biotechnology company developing gene therapies for the ...

Japanese ophthalmology company Santen Pharmaceutical (TYO: 4536) announced that it will launch Ryjusea Mini solution 0.025% ...

The public offering was led by Perceptive Advisors and Nantahala Capital, with participation from other new institutional biotech investors. Company CEO George Magrath and board chairman Cam Gallagher ...

Glenmark Pharmaceuticals Ltd on Thursday (March 20) said its arms Pharmaceuticals Inc., USA, has received final approval from ...

Glenmark Pharmaceuticals Inc., USA (Glenmark) has received final approval by the United States Food & Drug Administration (U.S. FDA) for Olopatadine Hydrochloride Ophthalmic Solution USP, 0.2% (OTC), ...

Glenmark Pharmaceuticals rose 1.95% to Rs 1,506.95 after its US subsidiary, Glenmark Pharmaceuticals Inc., USA, received approval from the US Food & Drug Administration (USFDA) for its Olopatadine ...

Advancements in medical imaging and computational methodologies have significantly transformed the field of ophthalmology, allowing for unmatched precision ...

Glenmark Pharma's stock rose after it said Glenmark Pharmaceuticals Inc., USA, has received final approval from the USFDA for ...

Glenmark Pharmaceuticals Inc, USA, has received final approval from the United States Food & Drug Administration (US FDA) for ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

Compr Ophthalmol Update. 2005;6(2):85-101. Antimicrobial medications for conjunctivitis are typically given as one drop (or one-half inch of ointment) four times daily for 5-7 days. Ointments have ...

Schoenherr Roofing is celebrating 30 years in business and has just opened its 4th location in Novi. As a leading roofing ...